PATENT CLAIM ANALYSIS

Application Number: 16076401
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["530", "387900"]

Abstract:
The present invention provides antibodies or antibody fragments binding to human IL-17C. In particular, it relates to antibodies or antibody fragments that have combined beneficial properties and are therefore useful for the treatment of humans having, for example, atopic dermatitis or psoriasis.

Claim (Index 1):
An antibody or antibody fragment specific for IL-17C wherein said antibody or antibody fragment cross-competes with an antibody comprising\n (a) the HCDR1 region of SEQ ID No.: 7, the HCDR2 region of SEQ ID No.: 8, the HCDR3 region of SEQ ID No.: 9, the LCDR1 region of SEQ ID No.: 13, the LCDR2 region of SEQ ID No.: 14 and the LCDR3 region of SEQ ID No.: 15, or (b) the HCDR1 region of SEQ ID No.: 20, the HCDR2 region of SEQ ID No.: 21, the HCDR3 region of SEQ ID No.: 22, the LCDR1 region of SEQ ID No.: 26, the LCDR2 region of SEQ ID No.: 27 and the LCDR3 region of SEQ ID No.: 28.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 96.0
- Lexical Diversity: 1.27027
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16058143', '10891972', '10564647', '15764918', '15058612']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7361112963495636
- 35 USC 102 Novelty (BERT): 0.6372798760448449
- Combined Prediction Score: 0.7262281543190918
- Mean Citation Score: 507.97095400000006
- Max Citation Score: 776.8428
- Similarity Product: 547.3919415734767

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test